Bluejay Diagnostics (BJDX) Revenue & Revenue Breakdown
Bluejay Diagnostics Revenue Highlights
Bluejay Diagnostics Revenue by Period
Bluejay Diagnostics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | -100.00% |
| 2022-12-31 | $249.04K | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Bluejay Diagnostics generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Bluejay Diagnostics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $1.45M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | -100.00% |
| 2022-06-30 | $249.04K | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Bluejay Diagnostics generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Bluejay Diagnostics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| IRIX | IRIDEX | $51.87M | $12.63M |
| HSCS | Heart Test Laboratories | $18.60M | $14.70K |
| NUWE | Nuwellis | $8.86M | $2.19M |
| INVO | INVO Bioscience | $3.02M | $1.58M |
| TIVC | Tivic Health Systems | $1.18M | $140.00K |
| TLIS | Talis Biomedical | $412.00K | - |
| MOTS | Motus GI | $319.00K | $64.00K |
| NXL | Nexalin | $110.75K | $26.84K |
| BJDX | Bluejay Diagnostics | - | - |
| BBLG | Bone Biologics | - | - |
BJDX Revenue FAQ
What is Bluejay Diagnostics’s yearly revenue?
Bluejay Diagnostics's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $249.04K, representing an increase of 100.00% compared to 2021. BJDX's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is Bluejay Diagnostics’s quarterly revenue?
Bluejay Diagnostics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). BJDX's quarterly revenue for Q4 2023 was $1.45M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is Bluejay Diagnostics’s revenue growth rate?
Bluejay Diagnostics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.